Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l204
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 444k | $2.6M | 0% | Jun 2026 |
|
| Alyeska Investment Group | 412k | $2.4M | 0% | Jun 2026 |
|
| Sio Capital Management | 327k | $1.9M | 0% | Jun 2026 |
|
| Marshall Wace | 247k | $1.4M | -8% | Jun 2026 |
|
| Woodline Partners | 177k | $1.0M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 176k | $1.0M | -2% | Jun 2026 |
|
| Baker Bros. Advisors | 83k | $479k | 0% | Jun 2026 |
|
| Hillhouse Capital Advisors | 76k | $440k | 0% | Jun 2026 |
|
| D. E. Shaw & Co | 67k | $384k | 505% | Jun 2026 |
|
| UBS Group | 60k | $346k | 62% | Jun 2026 |
|
| Geode Capital Management | 47k | $272k | -6% | Jun 2026 |
|
| Jane Street | 32k | $187k | 100% | Jun 2026 |
|
| BlackRock | 30k | $175k | 132% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 29k | $165k | 1% | Jun 2026 |
|
| Dimensional Fund Advisors | 21k | $121k | 100% | Jun 2026 |
|
| Verition Fund Management | 19k | $109k | 0% | Jun 2026 |
|
| Trexquant Investment | 12k | $71k | 100% | Jun 2026 |
|
| Renaissance Technologies | 11k | $62k | -89% | Jun 2026 |
|
| Rockefeller Capital Management | 10k | $58k | 0% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 4.7k | $27k | 389% | Jun 2026 |
|
| Golden State Wealth Management | 2.7k | $15k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 2.1k | $12k | 0% | Jun 2026 |
|
| Tower Research Capital | 359.00 | $2.1k | 452% | Jun 2026 |
|
| Jpmorgan Chase & Co | 344.00 | $1.9k | 100% | Jun 2026 |
|
| Morgan Stanley | 218.00 | $1.6k | -91% | Mar 2026 |
|
| SBI Securities | 126.00 | $726.994800 | 385% | Jun 2026 |
|
| Wells Fargo & Company | 100.00 | $577.000000 | -86% | Jun 2026 |
|
| FMR | 10.00 | $58.000000 | 100% | Jun 2026 |
|
| Zrc Wealth Management | 4.00 | $24.000000 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $17.000100 | 0% | Jun 2026 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of America Corporation | Mar 2026 | 230k | $1.7M |
| SummitTX Capital | Mar 2026 | 149k | $1.1M |
| Citadel Advisors | Mar 2026 | 54k | $404k |
| LPL Financial | Mar 2026 | 52k | $383k |
| Two Sigma Investments | Mar 2026 | 23k | $172k |
| XTX Topco | Mar 2026 | 14k | $106k |
| Quadrature Capital | Mar 2026 | 11k | $80k |
| Vanguard Global Advisers | Mar 2026 | 936.00 | $7.0k |
| Global Retirement Partners | Dec 2025 | 400.00 | $3.7k |